Impact of Multicohort Human Papillomavirus Vaccination on Cervical Cancer in Women Below 30 Years of Age: Lessons Learned From the Scandinavian Countries
The Journal of Infectious Diseases · 17.03.2025 · 231 (3) · e497-e500
DOI: 10.1093/infdis/jiae584 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Infectious Diseases, online erschienen am 21.11.2024. Verfasst von Ståle Nygård und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Research, Cancer Registry of Norway, Norwegian Institute of Public Health, Oslo, Norway. Hauptthemen laut MEDLINE: Uterine Cervical Neoplasms, Papillomavirus Vaccines, Papillomavirus Infections, Vaccination. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: MSD Norway.
Abstract (Originalsprache)
In Scandinavia, human papillomavirus (HPV) vaccination programs started in 2007–2008 in Sweden and Denmark with HPV vaccination offered to multiple cohorts of young girls, while in Norway this was offered to a single cohort only. Interestingly, in Sweden and Denmark, cervical cancer incidence in young women decreased markedly from 2017 to 2018, while in Norway a steady increase was seen until 2020. As the 3 countries are very similar in other factors important for cervical cancer incidence rates, like cervical cancer screening, the observed difference is most likely due to differences in the multicohort vaccination.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Research, Cancer Registry of Norway, Norwegian Institute of Public Health, Oslo, Norway.
- Zealand University Hospital, Nykøbing Falster, Denmark.
- Center of Cervical Cancer Elimination, Department of Clinical Science Intervention and Technology, Karolinska Institutet, Stockholm, Sweden.
ORCID-Profile: Ståle Nygård, Thea Eline Hetland Falkenthal, Tina Sture
Förderung
- MSD Norway
Zitieren
APA
Nygård, S., Hetland Falkenthal, T. E., Sture, T., Lynge, E., Elfström, M., & Nygård, M. (2025). Impact of Multicohort Human Papillomavirus Vaccination on Cervical Cancer in Women Below 30 Years of Age: Lessons Learned From the Scandinavian Countries. The Journal of Infectious Diseases, 231(3), e497-e500. https://doi.org/10.1093/infdis/jiae584
Vancouver
Nygård S, Hetland Falkenthal TE, Sture T, Lynge E, Elfström M, Nygård M. Impact of Multicohort Human Papillomavirus Vaccination on Cervical Cancer in Women Below 30 Years of Age: Lessons Learned From the Scandinavian Countries. The Journal of Infectious Diseases. 2025;231(3):e497-e500. doi:10.1093/infdis/jiae584
BibTeX
@article{Nygrd2025,
author = {Nygård, Ståle and Hetland Falkenthal, Thea Eline and Sture, Tina and Lynge, Elsebeth and Elfström, Miriam and Nygård, Mari},
title = {Impact of Multicohort Human Papillomavirus Vaccination on Cervical Cancer in Women Below 30 Years of Age: Lessons Learned From the Scandinavian Countries},
journal = {The Journal of Infectious Diseases},
year = {2025},
volume = {231},
number = {3},
pages = {e497--e500},
doi = {10.1093/infdis/jiae584}
}
EUVIMED